tiprankstipranks
Trending News
More News >
CorMedix’s Strong DefenCath Performance and Growth Prospects Justify Buy Rating
PremiumRatingsCorMedix’s Strong DefenCath Performance and Growth Prospects Justify Buy Rating
27d ago
RBC stays bullish on CorMedix as Q1 preliminary revenue reassures on near-term
Premium
The Fly
RBC stays bullish on CorMedix as Q1 preliminary revenue reassures on near-term
27d ago
CorMedix reports preliminary Q1 revenue $39M, consensus $32.2M.
Premium
The Fly
CorMedix reports preliminary Q1 revenue $39M, consensus $32.2M.
28d ago
CorMedix reports Q4 EPS 22c, consensus 14c
PremiumThe FlyCorMedix reports Q4 EPS 22c, consensus 14c
1M ago
Cormedix: Buy Rating Affirmed Amid Growth Potential and Strategic LDO Partnerships
Premium
Ratings
Cormedix: Buy Rating Affirmed Amid Growth Potential and Strategic LDO Partnerships
1M ago
Morning Movers: Mobileye jumps following Volkswagen ADAS partnership
Premium
The Fly
Morning Movers: Mobileye jumps following Volkswagen ADAS partnership
1M ago
Optimistic Buy Rating for Cormedix Driven by DefenCath’s Market Potential and Strategic Growth
PremiumRatingsOptimistic Buy Rating for Cormedix Driven by DefenCath’s Market Potential and Strategic Growth
2M ago
CorMedix initiated with an Outperform at Leerink
Premium
The Fly
CorMedix initiated with an Outperform at Leerink
2M ago
Elliott exits Cardinal Health, cuts NRG Energy in Q4
Premium
The Fly
Elliott exits Cardinal Health, cuts NRG Energy in Q4
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100